Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Bosaya. Always confirm against the full prescribing information.
100 interactions
Abatacept
The risk or severity of adverse effects can be increased when Denosumab is combined with Abatacept.
Level 1 evidence
Adalimumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Adalimumab.
Level 1 evidence
Aldesleukin
The risk or severity of adverse effects can be increased when Denosumab is combined with Aldesleukin.
Level 1 evidence
Alemtuzumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Alemtuzumab.
Level 1 evidence
Anakinra
The risk or severity of adverse effects can be increased when Denosumab is combined with Anakinra.
Level 1 evidence
Anifrolumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Anifrolumab.
Level 1 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Denosumab.
Level 2 evidence
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Denosumab is combined with Antilymphocyte immunoglobulin (horse).
Level 1 evidence
Antithymocyte immunoglobulin (rabbit)
The risk or severity of adverse effects can be increased when Denosumab is combined with Antithymocyte immunoglobulin (rabbit).
Level 1 evidence
Apremilast
The risk or severity of adverse effects can be increased when Denosumab is combined with Apremilast.
Level 1 evidence
Arsenic trioxide
The risk or severity of adverse effects can be increased when Denosumab is combined with Arsenic trioxide.
Level 1 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Denosumab.
Level 2 evidence
Enter your NPI to unlock 4 major interactions for Bosaya
Bosaya (Denosumab-Kyqq) has 378 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Bosaya (Denosumab-Kyqq) has 12 major, 247 moderate, and 119 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Bosaya. Always confirm against the full prescribing information.